Delisting, Listing Rule Failure, or Listing Transfer

Business Context and Reporting Period

Company: Coeptis Therapeutics Holdings, Inc. (Note: Metadata listed "Z Squared Inc." but filing text identifies Coeptis Therapeutics Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 17, 2024
Reporting Period: Event-based report regarding Nasdaq listing status.

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, or margin data. The only financial metric referenced is a regulatory threshold:

  • Minimum Stockholders' Equity Requirement: $5,000,000 (Company failed to meet this requirement for an initial extension).
  • Minimum Bid Price Requirement: $1.00 per share (Company failed to maintain this for 30 consecutive business days).

Material Changes and Listing Status

Nasdaq Delisting Notice and Extension:

  • Original Notice: On January 29, 2024, Nasdaq notified the Company of non-compliance with the $1.00 minimum bid price requirement.
  • Initial Compliance Period: The Company was granted 180 days (until July 29, 2024) to regain compliance but failed to do so.
  • Appeal Outcome: On September 17, 2024, Nasdaq granted the Company an extension through January 15, 2025, to regain compliance with the Minimum Bid Price Requirement.
  • Current Status: The Company's Common Stock (Symbol: COEP) and Warrants (Symbol: COEPW) remain listed on the Nasdaq Capital Market.

Outlook, Risks, and Management Commentary

Management Commentary:

  • The Company will continue to monitor the closing bid price of its Common Stock.
  • The Company intends to seek to regain compliance with all applicable Nasdaq requirements within the allotted period.
Risks and Contingencies:
  • Delisting Risk: If the Company fails to regain compliance by January 15, 2025 (or any further extensions granted), Nasdaq will provide notice that the Common Stock will be subject to delisting.
  • Equity Requirement: The Company previously failed to qualify for an extension because it did not meet the $5,000,000 minimum stockholders' equity initial listing requirement.

Investor Verification Checklist

  • Verify the current closing bid price of COEP to assess progress toward the $1.00 minimum requirement.
  • Review the Company's most recent 10-Q or 10-K to determine current stockholders' equity levels relative to the $5,000,000 threshold.
  • Monitor for any future 8-K filings regarding further extensions or delisting notices prior to the January 15, 2025 deadline.
  • Confirm the trading status of both Common Stock (COEP) and Warrants (COEPW) on the Nasdaq Capital Market.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.